-->
-->
-->
USA Genome Sequencing Market Analysis, 2020 research report depicts a deep-dive market analysis of statistics of USA Genome Sequencing market which consists of regional market size, market forecast, CAGR market segmentation, market shares of diverse regions and countries, market share of various end users, applications, product type, technologies, competitive benchmarking, etc.
According to MarkNtel Advisors’ research report titled “USA Genome Sequencing Market Analysis, 2020”, the USA Genome Sequencing market is anticipated to grow at a considerable CAGR during 2020-25F on an account of bolstering investment in genomics medicine and rising partnerships among the market players to accelerate the adoption of genomics in order to support the increasing demand for clinical grade genomic information at lower cost.
Market Segmentation
Sequencing by Synthesis to Dominate
Based on Technology, Sequencing by Synthesis is estimated to dominate the market by 2025. The growth is attributed to it is widely used in sequencing protocol by many of the DNA sequencing platforms. Moreover, robust developments in technology are dramatically reducing costs is projected to promulgate the market growth of Genome Sequencing market in the near future as stated in the MarkNtel Advisors’ research report “USA Genome Sequencing Market Analysis, 2020”.
Academic & Government Research Institute Accounted the Substantial Market Share
Based on End User, Academic & Government Research Institute segment acquired the significant market share in 2019 as genome sequencing is widely used for practical implementation of data analysis in academic and government research institutes due to dominance of a large number of research and development projects.
Market Opportunities
The market growth of the genome sequencing is attributed to launch of innovative sequencing systems by the key players, escalating demand for a platform to support deeper sequencing and rising clinical adoption of genome sequencing in rare and undiagnosed genetic diseases. Moreover, the escalating number of patients with chronic diseases, declining cost of sequencing, along with surging government funding for health research in sequencing and also to establish genome centers are some of the factors for the growth of the market in the near future.
Impact of COVID-19
COVID-19 has led to the growth of genome sequencing as it is used to efficiently understand COVID-19 and its spread. Moreover, the sequencing helps the researches to understand coronavirus adapts to its human host and its impact on the vaccines and drug treatments which can be discovered in the near future through monitoring the virus.
Competitive Landscape
According to MarkNtel Advisors, the key players with a considerable market share in the USA Genome Sequencing market include Abbott, Roche, Agilent, Perkinelmer, Siemens, Illumina, ThermoFisher, Pacific Biosciences, Integrated DNA Technologies, Cytiva etc.
Key Questions Answered in the Market Research Report
Market Outlook, Segmentation and Statistics
Frequently Asked Questions
Q. What is the historical year, base year and forecast year considered in the research report on USA Genome Sequencing Market?
A. The historical data has been provided since 2015, while the base year is 2019 and the data is forecast up-to 2025.
Q. What are the units or denomination for measuring market value and volume in the report?
A. The market size/industry size or the market value is measured in terms of USD Billion.
Q. What would be the growth rate or CAGR of USA Genome Sequencing Market during 2020-25?
A. The growth rate of USA Genome Sequencing Market during 2020-25 is forecast to grow at a considerable CAGR.
Q. Who are the key competitors or players operating in USA Genome Sequencing Market?
A. Abbott, Roche, Agilent, Perkinelmer, Siemens, Illumina, ThermoFisher, Pacific Biosciences, Integrated DNA Technologies, Cytiva etc., are few of the leading players in the USA Genome Sequencing Market.
Q. Which technology segment would emerge as an opportunity area for players in USA Genome Sequencing Market?
A. Sequencing by synthesis delivery deployment is expected to attain the highest CAGR during the forecast period and maintain its significant market share.
Q. Which end-user would emerge as an opportunity area for players in USA Genome Sequencing Market?
A. Hospital and Clinics grabbed a significant market share continue to grow at a highest CAGR, presenting immense opportunities for market players of USA Genome Sequencing Market.
